Related Experiment Videos
A hungarian study on Werdnig-Hoffmann disease.
1Department of Human Genetics and Teratology, National Institute of Hygiene, Budapest, Hungary.
Journal of Medical Genetics
|December 1, 1989
Summary
Werdnig-Hoffmann disease, a severe form of spinal muscular atrophy, affects 1 in 10,000 newborns in Hungary. This prevalence exceeds previous English studies, with no increased fetal death risk observed in mothers of affected infants.
Area of Science:
- Neurology
- Genetics
- Epidemiology
Background:
- Werdnig-Hoffmann disease, a severe form of spinal muscular atrophy (SMA), is a significant genetic neuromuscular disorder.
- Accurate prevalence data is crucial for understanding disease burden and planning healthcare resources.
- Previous epidemiological studies have provided varying estimates of Werdnig-Hoffmann disease incidence.
Purpose of the Study:
- To determine the prevalence of Werdnig-Hoffmann disease in Hungary.
- To compare Hungarian prevalence rates with those reported in other populations.
- To investigate potential risk factors such as fetal death rates and recurrence in siblings.
Main Methods:
- Retrospective analysis of livebirth data in Hungary between 1973 and 1980.
- Inclusion of confirmed Werdnig-Hoffmann disease cases.
- Comparison of observed prevalence with published data from English studies.
Main Results:
- The observed prevalence of Werdnig-Hoffmann disease in Hungary was 0.66 per 10,000 livebirths.
- The estimated true prevalence is 1 per 10,000 livebirths, higher than previously reported English studies.
- No elevated fetal death rate was found in mothers of index patients; recurrence in siblings was 32%.
Conclusions:
- Werdnig-Hoffmann disease prevalence in Hungary is estimated at 1 in 10,000 livebirths.
- This incidence rate is higher than previously documented in English populations.
- The findings highlight the importance of regional epidemiological data for understanding rare genetic diseases.